A Clinical Study on Levosimendan Improvement of Prognosis of ARDS Patients by Optimizing Pulmonary Hemodynamics

NCT04020003 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

ARDS, Human

Interventions

DRUG: Levosimendan

Sponsor

Shenzhen Second People's Hospital